Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Investment Chat Board Lawsuits -- Ignore unavailable to you. Want to Upgrade?

To: William Partmann who wrote (499)	7/26/2000 7:07:34 PM
From: Ben Wa	Read Replies (1) \| Respond to of 12465

you might want to look at how elan gets their earnings. If you took money out of your left pocket and put it into your right pocket, would that enrich you? Just because elan stock goes up (or down), that does not mean that what is referred to as "quality of earnings" is high. MSTR went up a lot too. Does that mean that if an analyst prior to the stock going up had said that the accounting of MSTR was creative, that such an analyst would be a moron for saying so? I do not think Elan is looking forward to any magnifying glass. But then again, I may be wrong.

To: William Partmann who wrote (499)	7/30/2000 2:35:24 PM
From: Jeffrey S. Mitchell	Read Replies (3) \| Respond to of 12465

Re: [CSFB] A $1m Message Board Precedent? A $1m Message Board Precedent? Brett Pope Jul 13 2000 Global investment bank Credit Suisse First Boston (CSFB) has filed a $1m lawsuit against 11 individuals who post messages on the Yahoo message board about Elan [ELN], an Irish pharmaceutical company. The lawsuit claims that the authors posted messages that contained false and defamatory statements about CSFB and David Maris, one of its research analysts. While the lawsuit may draw some attention to Elan, it will have no effect on the company’s business. I maintain my buy rating on Elan. Maris covers specialty pharmaceutical stocks for CSFB, including Elan, which he has long rated a hold. While I disagree with his opinion, he is entitled to it. However, many of the posters on the Elan message board have ridiculed Maris for his reports and opinions on Elan. I've had a look at some of the messages on Elan’s board and while some of the personal attacks are unnecessary, I generally find the board to be much more professional and informative than most of others I've seen. The outcome of this lawsuit will be closely watched because it could have a profound impact on the use of message boards and how information is exchanged over the Internet. I personally believe the lawsuit is frivolous and hope it will be dismissed. At StreetAdvisor, we have all been subject to ridicule on message boards--it comes with the job. One of the advantages of our reports, however, is that they are always unbiased. We have no reason to give a recommendation unless we believe it. Unfortunately, the sell-side analysts at Wall Street firms cannot make the same claim to their customers. For more on the Wall Street bias and why investors need an impartial champion, click here. Brett is a health care analyst for StreetAdvisor.com. As a full-time employee of StreetAdvisor.com, Brett is prohibited from actively trading individual stocks, options, and bonds. As per company policy, Brett has not opened a new position in a stock since February 1, 2000. Copyright 2000, StreetAdvisor.com, Inc. streetadvisor.com